- Exchange: NYSE MKT LLC
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Palatin Technologies Inc
+ Add to WatchlistPTN:US
0.6400 USD 0.00000.00%As of 20:04:07 ET on 05/20/2013.
Snapshot for Palatin Technologies Inc (PTN)
| Open: | 0.6600 | Day's Range: | 0.6300 - 0.6600 | Volume: | 72,344 |
|---|---|---|---|---|---|
| Previous Close: | 0.6400 | 52wk Range: | 0.4000 - 1.2000 | 1-Yr Rtn: | +5.79% |
Key Statistics for PTN
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(06/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.3500 |
| Est. EPS (USD) (06/2013) | -0.2150 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 24.93 |
| Shares Outstanding (M) | 38.95 |
| 30 Day Average Volume | 150,426 |
| Price/Book (mrq) | 0.7922 |
| Price/Sale (ttm) | 1,485.7210 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 09/10/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PTN
Company Profile & Key Executives for PTN
Palatin Technologies, Inc. is a biopharmaceutical company. The Company researches produces for the treatment of male and female sexual disfunction, congestive heart failure, obesity, and cachexia.
| Carl SpanaPresident/CEO/Co-Founder | Stephen T WillsExec VP/CFO/COO/Treasurer/Secy |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PTN News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page